Functional Analytics Core
功能分析核心
基本信息
- 批准号:10643964
- 负责人:
- 金额:$ 24.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-06-01 至 2024-05-31
- 项目状态:已结题
- 来源:
- 关键词:AccelerationAutoimmuneBasic ScienceBig DataBiologicalBiological databasesBiologyCRISPR/Cas technologyCaliforniaCellsCommunitiesCommunity OutreachConsultationsCutaneousDataData AnalysesDiseaseEffectivenessEpigenetic ProcessExperimental DesignsFemaleGene ExpressionGene Expression ProfilingGenerationsGenesGenetic CodeGenetic EngineeringGenomicsGenotype-Tissue Expression ProjectGoalsHumanImmuneIndividualInfrastructureKnock-inKnock-outKnowledgeLos AngelesMediatingMichiganMissionMolecularMusMutagenesisNational Institute of Arthritis, and Musculoskeletal, and Skin DiseasesPathologicPhenotypePublicationsRNAReportingResearchResearch InfrastructureResearch PersonnelResourcesServicesSkinSystemSystems BiologyTechniquesTechnologyTrainingTraining and EducationTranscriptTransfectionTranslatingTranslational ResearchUnited States National Institutes of HealthUniversitiesbioinformatics resourcecell typecytokinedata analysis pipelinedata integrationdata sharingdesigndifferential expressionepigenomicsgenetic manipulationgenome editinggenome wide association studygenome-widegenomic datahigh throughput screeninginnovationinsightkeratinocytemalemembermutantnovelrepairedskin disorderstatisticstooltraining opportunitytranscription factortranscriptomicsweb interface
项目摘要
PROJECT SUMMARY
In recent years our abilities to manipulate the genetic code of individual cells, through CRISPR/Cas9 induced
mutagenesis, and generation of high-throughput data have rapidly advanced. However, major bottlenecks
remain; the use of CRISPR/Cas9 remains technically challenging, particularly in keratinocytes, which are much
more challenging to transfect than other cell-types. Furthermore, the ability of most research groups to
analyze high-throughput data and incorporate it into a meaningful biologic and pathologic context remains
limited. Therefore, there is an enormous need for expertise and capabilities both for CRISPR/Cas9 services as
well as bioinformatic resources to translate the vast information and connect it with relevant biological or
disease-specific situation. To fill this critical gap, the University of Michigan Skin Biology and Resource-based
Center (UM-SBDRC) Functional Analytics Core (FAC) will provide sophisticated infrastructure, resources,
expertise, and training opportunities at the University of Michigan under the UM-SBDRC. The FAC is in line
with the NIAMS mission to provide needed research infrastructure, pooled facilities, services, and resources to
groups of investigators conducting research on skin biology and diseases. The goal of the FAC is to
accelerate, enhance, and enrich the effectiveness of ongoing basic and translational research, and to help
bring outside investigators into the field of cutaneous biology. This will be achieved through the two aims of
the FAC: In Aim 1 where we provide CRISPR/Cas9 genome editing services in keratinocytes for generation of
both knock-out and knock-in keratinocytes as well as functional characterization of mutant keratinocyte lines,
and Aim 2, where we provide access to systems biology analyses, disease- and cytokine-specific gene
expression profiling, and training. These services are not widely available for the cutaneous research
community, and the services, resources, and techniques made available through this Core will provide UM-
SBDRC Members with highly innovative approaches that will promote and accelerate ongoing research and
help attract new research teams into the fold of cutaneous research.
项目总结
近年来,我们通过CRISPR/Cas9诱导的操纵单个细胞遗传密码的能力
突变和高通量数据的生成已经迅速推进。然而,主要瓶颈是
CRISPR/Cas9的使用在技术上仍然具有挑战性,特别是在角质形成细胞中,角质形成细胞
与其他类型的细胞相比,更具挑战性的是转基因。此外,大多数研究小组的能力
分析高通量数据,并将其整合到有意义的生物和病理背景中
有限的。因此,对CRISPR/CAS9服务的专门知识和能力都有巨大的需求
以及生物信息资源来翻译大量信息,并将其与相关的生物或
特定于疾病的情况。为了填补这一关键空白,密歇根大学皮肤生物学和资源部
中心(UM-SBDRC)功能分析核心(FAC)将提供复杂的基础设施、资源、
在密歇根大学UM-SBDRC下的专业知识和培训机会。联邦航空局正在排队
NIAMS的使命是提供所需的研究基础设施、汇集的设施、服务和资源,以
进行皮肤生物学和疾病研究的研究人员小组。外交事务委员会的目标是
加速、增强和丰富正在进行的基础研究和翻译研究的有效性,并帮助
将外部研究人员带入皮肤生物学领域。这将通过以下两个目标来实现
FAC:在目标1中,我们在角质形成细胞中提供CRISPR/Cas9基因组编辑服务以生成
敲除和敲入角质形成细胞以及突变角质形成细胞系的功能特征,
和目标2,在那里我们提供系统生物学分析、疾病和细胞因子特异性基因
表情分析和训练。这些服务并不广泛地用于皮肤研究
社区,以及通过此核心提供的服务、资源和技术将提供UM-
SBDRC成员具有高度创新的方法,将促进和加快正在进行的研究和
帮助吸引新的研究团队进入皮肤研究领域。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Johann Eli Gudjonsson其他文献
Neutrophilic granulocyte-derived B-cell activating factor supports B cells in skin lesions in hidradenitis suppurativa
- DOI:
10.1016/j.jaci.2022.10.034 - 发表时间:
2023-04-01 - 期刊:
- 影响因子:
- 作者:
Robert Sabat;Deimantė Šimaitė;Johann Eli Gudjonsson;Theresa-Charlotte Brembach;Katrin Witte;Torben Krause;Georgios Kokolakis;Eckart Bartnik;Christos Nikolaou;Natascha Rill;Béma Coulibaly;Clément Levin;Matthias Herrmann;Gabriela Salinas;Thomas Leeuw;Hans-Dieter Volk;Kamran Ghoreschi;Kerstin Wolk - 通讯作者:
Kerstin Wolk
Johann Eli Gudjonsson的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Johann Eli Gudjonsson', 18)}}的其他基金
ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium
ELLIPSS:阐明银屑病皮肤和滑膜的免疫内型概况
- 批准号:
10451910 - 财政年份:2022
- 资助金额:
$ 24.88万 - 项目类别:
ELLIPSS: ELucidating the Landscape of Immunoendotypes in Psoriatic Skin and Synovium
ELLIPSS:阐明银屑病皮肤和滑膜的免疫内型概况
- 批准号:
10595620 - 财政年份:2022
- 资助金额:
$ 24.88万 - 项目类别:
Epigenetic regulation of sexually dimorphic immune responses in keratinocytes
角质形成细胞中性二态性免疫反应的表观遗传调控
- 批准号:
10215655 - 财政年份:2021
- 资助金额:
$ 24.88万 - 项目类别:
Epigenetic regulation of sexually dimorphic immune responses in keratinocytes
角质形成细胞中性二态性免疫反应的表观遗传调控
- 批准号:
10383754 - 财政年份:2021
- 资助金额:
$ 24.88万 - 项目类别:
相似国自然基金
Autoimmune diseases therapies: variations on the microbiome in rheumatoid arthritis
- 批准号:31171277
- 批准年份:2011
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Study of Neuropilin-1 as a potential marker of self-reactive Th cells in autoimmune neuroinflammation
Neuropilin-1 作为自身免疫性神经炎症中自身反应性 Th 细胞潜在标志物的研究
- 批准号:
24K10278 - 财政年份:2024
- 资助金额:
$ 24.88万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Shared and distinct genetic architecture of autoimmune and hormonal alopecias
自身免疫性脱发和激素性脱发的共同和独特的遗传结构
- 批准号:
MR/X030466/1 - 财政年份:2024
- 资助金额:
$ 24.88万 - 项目类别:
Research Grant
Effects of maternal immune activation on autoimmune diseases in offsprings
母体免疫激活对后代自身免疫性疾病的影响
- 批准号:
23H02155 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Environmental factors and risk of autoimmune rheumatic disease incidence and serology
环境因素和自身免疫性风湿病发病率和血清学的风险
- 批准号:
498306 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别:
Operating Grants
Autoantibodies and antibody-secreting cells in neurological autoimmune diseases: from biology to therapy
神经性自身免疫性疾病中的自身抗体和抗体分泌细胞:从生物学到治疗
- 批准号:
479128 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别:
Operating Grants
BIOlogic drug safety and effectiveness interNational pharmacoepidemiologIC study in pregnant women with autoimmune disorders and asthma and their children (BIONIC)
患有自身免疫性疾病和哮喘的孕妇及其子女的生物药物安全性和有效性国际药物流行病学研究(BIONIC)
- 批准号:
493526 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别:
Operating Grants
Functional consequences of intergenic autoimmune disease risk variants
基因间自身免疫性疾病风险变异的功能后果
- 批准号:
10655161 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别:
IPP: AUTOIMMUNE DISEASES STATISTICAL AND CLINICAL COORDINATING CENTER (ADSCCC)
IPP:自身免疫性疾病统计和临床协调中心 (ADSCCC)
- 批准号:
10788032 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别:
PTSD and Autoimmune Disease: Towards Causal Effects, Risk Factors, and Mitigators
创伤后应激障碍 (PTSD) 和自身免疫性疾病:因果效应、危险因素和缓解措施
- 批准号:
10696671 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别:
Build to LEAD – Building partnerships to Link the Exposome to Autoimmune Disease
构建引领 — 建立合作伙伴关系,将暴露组与自身免疫性疾病联系起来
- 批准号:
10871040 - 财政年份:2023
- 资助金额:
$ 24.88万 - 项目类别:














{{item.name}}会员




